Cencora, Inc.
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
Cencora to Report Q3 Earnings: Is a Beat Likely for the Stock?
COR's Q3 results could reflect specialty pharma strength, oncology expansion and margin gains, even as pricing dynamics and GLP-1 trends pressure revenues.
Here's Why You Should Add Cencora Stock to Your Portfolio Now
COR's specialty expansion, supply-chain investments and international momentum support growth, though pricing, debt and regulation pose risks.
Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release
CONSHOHOCKEN, Pa., July 01, 2026--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Third Quarter of Fiscal 2026 on Wednesday, August 5, 2026, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on August 5, 2026.
Cencora Pick of the Week at Smart Insider Following Chairman's Share Purchase
Cencora (COR) was Smart Insider's stock pick of the week after Chair Mark Durcan bought $1 million i
Cencora (COR) Stock After Recent Pullback And DCF Valuation Gap
If you are wondering whether Cencora stock is priced for opportunity or already reflects its strengths, the current setup invites a closer look at what investors are really paying for. Cencora shares last closed at US$286.13, with the stock up 5.5% over the past week and 6.2% over the past month, while still showing a 15.6% decline year to date and a 3.9% decline over the past year. These shorter term moves sit alongside a longer 3 year return of 53.8% and a 5 year return of 158.3%. This...
Cencora (COR) Launches Nucleus Pilot As Verizon Executive Joins As CHRO
Cencora (NYSE:COR) has launched a multi-site pilot of its upgraded Nucleus inventory management solution for specialty physician practices. The pilot focuses on improving medication workflow efficiency and inventory visibility across participating sites. The company has appointed Samantha Hammock, formerly of Verizon, as Chief Human Resources Officer, succeeding Silvana Battaglia. These developments reflect operational and leadership changes that may affect Cencora's specialty care...
3 Big Reasons to Love Cencora (COR)
Over the past six months, Cencora’s stock price fell to $287.06. Shareholders have lost 15.8% of their capital, which is disappointing considering the S&P 500 has climbed by 6.2%. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
B of A Securities Maintains Neutral on Cencora, Raises Price Target to $285
B of A Securities analyst Michael Funk maintains Cencora (NYSE:COR) with a Neutral and raises the price target from $280 to $285.
Wells Fargo Maintains Overweight on Cencora, Lowers Price Target to $331
Wells Fargo analyst Stephen Baxter maintains Cencora (NYSE:COR) with a Overweight and lowers the price target from $429 to $331.
Cencora Q2 Earnings Call Highlights
Cencora (NYSE:COR) reported higher fiscal second-quarter adjusted earnings and operating income, while management raised its full-year adjusted EPS outlook and said it would resume opportunistic share repurchases. The pharmaceutical distribution and healthcare services company also lowered its full-
Congressional Trades in $COR
Insider Trades (Form 4)
GREENBERG LON R
Krikorian Lazarus
Campbell Elizabeth S
NALLY DENNIS M
Cooper Ellen
Tyler Lauren M
Campbell Elizabeth S
Battaglia Silvana
Key People
GREENBERG LON R
Director
Krikorian Lazarus
SVP & Chief Accounting Officer
Campbell Elizabeth S
Executive Vice President
Boratto Eva C
Chief Financial Officer
Tyler Lauren M
Director
DURCAN DERMOT MARK
Director
NALLY DENNIS M
Director
Cleary James F
Chief Financial Officer
Battaglia Silvana
Executive Vice President
Cooper Ellen
Director
Political Giving
$207,000 given to 37 candidates across 87 disclosed contributions (FEC Schedule A).
Earl Leroy Carter
Nanette Barragan
Lori Trahan
Mary Gay Scanlon
John Curtis
Dave McCormick
Ashley Moody
Carol Devine Miller
Adrian Smith
Doris O. Matsui
Katherine M. Clark
Diana Harshbarger
Terri A. Sewell
Blake Moore
Markwayne Mullin
Nicole Malliotakis
Thomas R. Suozzi
Thomas Suozzi
Ron Wyden
Bradley S. Schneider
+ 17 more recipients not shown.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro